Literature DB >> 29699735

Improving outcomes in schizophrenia by preventing early relapses.

Robert B Zipursky1, Ofer Agid2, Gary Remington2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29699735     DOI： 10.1016/S2215-0366(18)30124-X

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  3 in total

1.  Reconsidering brain tissue changes as a mechanistic focus for early intervention in psychiatry.

Authors:  Lena Palaniyappan; Niron Sukumar
Journal:  J Psychiatry Neurosci       Date:  2020-11       Impact factor: 6.186

2.  An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders.

Authors:  Nadia E Crellin; Stefan Priebe; Nicola Morant; Glyn Lewis; Nick Freemantle; Sonia Johnson; Rob Horne; Vanessa Pinfold; Lyn Kent; Ruth Smith; Katherine Darton; Ruth E Cooper; Maria Long; Jemima Thompson; Lisa Gruenwald; Robert Freudenthal; Jacki L Stansfeld; Joanna Moncrieff
Journal:  BMC Psychiatry       Date:  2022-03-15       Impact factor: 3.630

3.  Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).

Authors:  R Segarra; M Recio-Barbero; M Sáenz-Herrero; O Mentxaka; J Cabezas-Garduño; J I Eguíluz; L F Callado
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.